Cover

Guides Changing treatment and drug resistance

Using T-20

T-20 is also called enfuvirtide or Fuzeon. It is an entry inhibitor that will work against HIV that is resistant to other drug classes.

T-20 has to be used in combination with other active drugs if it is to provide long-term benefit. Do not use T-20 if it is the only active drug in your combination.

T-20 is given by subcutaneous injection twice a day, and training is provided so you can do this yourself at home.

If you have resistance to all available drugs, and your CD4 count is stable, almost at any level above 50 cells/mm3, it is be better to save T-20 until you can use it with these or other new drugs.

If your CD4 count is less that 50 cells/mm3 then T-20 can boost your CD4 count in the short term, even though resistance can easily develop if viral load stays detectable.

T-20 is an important option. As well as reducing viral load it can protect you from developing resistance to the other drugs in your combination.

T-20 may be a drug that you only need to use for a limited period until a new drug becomes available.

However inconvenient or difficult a ‘salvage’ regimen is, it is not forever. It is a means to get through a very risky period, in order to access better treatments when they become available.


February 2011

Decisions relating to your treatment should always be taken in consultation with your doctor. Information in this guide is intended to support those discussions.

Authors and referencesTranslationsAbout our guidesGuides index

This guide's available in UK clinics (can't find it?)

We comply with the HONcode standard for trustworthy health information: verify here



HIV i-Base
Treatment phoneline: 0808 800 6013 • Mon-Wed 12-4pm • Office: 020 7407 8488 • Email: admin@i-base.org.uk • Website: www.i-base.info